title: [Improper therapy in phlebology. Anticoagulants].
abstract: In phlebology, an anticoagulant treatment is usually called for in the fight against thrombosis. The favourable short-term development of most phlebites means that an anticoagulant treatment should not be used unless there are serious risks involved in the various complications observed. This treatment may therefore be used, on condition that diagnosis is certain, that the risks involved are serious enough; the least restrictive, least expensive form of treatment is preferable, provided that it is as effective, of course; the conditions of applications should be scrupulously upheld: no contraindications, the cooperation of the patient, quality of the biological controls etc. If these conditions are respected, the anticoagulant treatment combines efficiency and safety to a degree which places it foremost among anti-thrombotic methods, after physiotherapy.
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D006801:Humans; D010689:Phlebitis / Q000150:complications / Q000188:drug therapy; D012306:Risk; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D000925:Anticoagulants
vernacular_title: La thérapeutique abusive en phlébologie. Les anticoagulants.